ES2165840T3 - Vacunas para la hepatitis a. - Google Patents
Vacunas para la hepatitis a.Info
- Publication number
- ES2165840T3 ES2165840T3 ES91903208T ES91903208T ES2165840T3 ES 2165840 T3 ES2165840 T3 ES 2165840T3 ES 91903208 T ES91903208 T ES 91903208T ES 91903208 T ES91903208 T ES 91903208T ES 2165840 T3 ES2165840 T3 ES 2165840T3
- Authority
- ES
- Spain
- Prior art keywords
- virus
- hepatitis
- incorporated
- dna
- vaccine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 208000006454 hepatitis Diseases 0.000 title abstract 2
- 231100000283 hepatitis Toxicity 0.000 title abstract 2
- 241000700605 Viruses Species 0.000 abstract 4
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 206010019799 Hepatitis viral Diseases 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 230000001524 infective effect Effects 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 230000006798 recombination Effects 0.000 abstract 1
- 238000005215 recombination Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24141—Use of virus, viral particle or viral elements as a vector
- C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
- C12N2770/32422—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Valve Device For Special Equipments (AREA)
- Valve-Gear Or Valve Arrangements (AREA)
- Glass Compositions (AREA)
- Saccharide Compounds (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Abstract
UN POLIPEPTIDO AISLADO QUE COMPRENDE UNA IMPORTANTE PARTE ANTIGENICA DE AL MENOS UN EPITOPO DEL VIRUS HEPATITIS A, ESTANDO EL POLIPEPTIDO LIBRE DE MATERIAL INFECCIOSO. EL POLIPEPTIDO ES EL PRODUCTO EXPRIMIDO DE UN MOLECULA DNA QUE HA SIDO INCORPORADA A UN VIRUS, PREFERENTEMENTE VIRUS DE VACUNA, UTILIZANDO TECNOLOGIA DNA DE RECOMBINACION. ESTE PRODUCTO, DEL VIRUS RECOMBINANTE QUE CONTIENE EL CODIGO MOLECULAR DNA PARA EL, PUEDE INCORPORARSE A UNA VACUNA PARA INMUNIZAR CONTRA EL VIRUS DE HEPATITIS A.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB909002387A GB9002387D0 (en) | 1990-02-02 | 1990-02-02 | Improvements relating to the prevention of hepatitis |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2165840T3 true ES2165840T3 (es) | 2002-04-01 |
Family
ID=10670339
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES91903208T Expired - Lifetime ES2165840T3 (es) | 1990-02-02 | 1991-02-04 | Vacunas para la hepatitis a. |
Country Status (9)
Country | Link |
---|---|
US (1) | US5605692A (es) |
EP (1) | EP0513090B1 (es) |
JP (1) | JP3086250B2 (es) |
AT (1) | ATE205220T1 (es) |
CA (1) | CA2072982C (es) |
DE (1) | DE69132717T2 (es) |
ES (1) | ES2165840T3 (es) |
GB (1) | GB9002387D0 (es) |
WO (1) | WO1991011460A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6838237B2 (en) * | 1996-04-19 | 2005-01-04 | The United States Of America As Represented By The Department Of Health And Human Services | Antigenically reactive regions of the hepatitis a virus polyprotein |
US6368602B1 (en) * | 2000-06-16 | 2002-04-09 | Hadasit Medical Research Services And Development Ltd | Mucosal immunization against hepatitis A virus (HAV) through rectal administration of HAV vaccine |
CA2698392C (en) * | 2007-09-04 | 2019-12-03 | Baoming Jiang | Thermal inactivation of rotavirus |
CN103923882B (zh) * | 2013-08-09 | 2016-09-28 | 北京科兴生物制品有限公司 | 甲肝病毒单克隆抗体及其应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4614793A (en) * | 1983-10-14 | 1986-09-30 | Merck & Co., Inc. | Hepatitis A--subunit antigen |
EP0154587B1 (en) * | 1984-03-02 | 1991-05-15 | Merck & Co. Inc. | Fragments of dna which encode peptides capable of inducing in vivo the synthesis of anti-hepatitis a virus antibodies |
SU1469856A1 (ru) * | 1986-07-31 | 1990-09-30 | Институт биоорганической химии им.М.М.Шемякина | Способ конструировани рекомбинантной плазмидной ДНК, кодирующей синтез полипептидных субстанций против гепатита А |
-
1990
- 1990-02-02 GB GB909002387A patent/GB9002387D0/en active Pending
-
1991
- 1991-02-04 CA CA002072982A patent/CA2072982C/en not_active Expired - Fee Related
- 1991-02-04 WO PCT/GB1991/000163 patent/WO1991011460A1/en active IP Right Grant
- 1991-02-04 EP EP91903208A patent/EP0513090B1/en not_active Expired - Lifetime
- 1991-02-04 JP JP03503913A patent/JP3086250B2/ja not_active Expired - Fee Related
- 1991-02-04 AT AT91903208T patent/ATE205220T1/de not_active IP Right Cessation
- 1991-02-04 ES ES91903208T patent/ES2165840T3/es not_active Expired - Lifetime
- 1991-02-04 DE DE69132717T patent/DE69132717T2/de not_active Expired - Fee Related
- 1991-02-04 US US07/916,149 patent/US5605692A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0513090A1 (en) | 1992-11-19 |
JP3086250B2 (ja) | 2000-09-11 |
CA2072982A1 (en) | 1991-08-03 |
GB9002387D0 (en) | 1990-04-04 |
WO1991011460A1 (en) | 1991-08-08 |
JPH05503524A (ja) | 1993-06-10 |
ATE205220T1 (de) | 2001-09-15 |
EP0513090B1 (en) | 2001-09-05 |
CA2072982C (en) | 1999-09-07 |
US5605692A (en) | 1997-02-25 |
DE69132717D1 (en) | 2001-10-11 |
DE69132717T2 (de) | 2002-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8105388A1 (es) | Un metodo para mantener, replicar y expresar por lo menos una porcion del genoma de un virus n.p. | |
DK0584348T3 (da) | Genetisk vaccine mod immundefektvirusser | |
ES2150416T3 (es) | Vacuna virica defectiva producida por una linea celular complementada en trans. | |
ES2059565T3 (es) | Virus mva de la vacuna, recombinante. | |
ES2157522T3 (es) | Cepas de vacunas europeas del virus del sindrome respiratorio reproductor porcino (prrsv). | |
DE3278344D1 (en) | Stabilization of influenza virus vaccine | |
DE69535018D1 (de) | Papillomavirus vakzine | |
ES2061708T3 (es) | Virus recombinante de la viruela de la gallina, vectores de expresion de proteinas heterologas y vacunas para aves de corral derivadas de este virus. | |
DE69737886D1 (de) | Infektioese rna virus-klone, vakzine und davon abgeleitete diagnostische assays | |
CO4960659A1 (es) | Vacuna que comprende un antigeno de virus de la hepatitis b y un antigeno del virus herpes simplex | |
FI950405A (fi) | Heikosti immunogeenisten antigeenien ja synteettisten peptidikantajien konjugaatit sekä niitä sisältävät rokotteet | |
DE3853210D1 (de) | Verwendung eines viralen glykoprotein-impstoffes für intranasale immunisierung gegen eine virusinfektion. | |
KR930703435A (ko) | 단순 포진 비루스-1 결실 변종 및 그의 백신 | |
KR860004146A (ko) | 경구용 백신의 제조방법 | |
ES2145000T3 (es) | Virus recombinante del avipox. | |
IL77694A (en) | Canine parvovirus vaccines comprising viruses of the canine parvovirus strain 154 or viruses derived therefrom by additional cell culture passaging | |
NO922953D0 (no) | Rekombinant fremstilt blodfaktorer og fremgangsmaate for ekspresjon av blodfaktorene, samt vacciniavirusrekombinanter | |
ATE103328T1 (de) | Fuer ein glykoprotein des aids-virus kodierende virus-vektoren, vakzin und antikoerper. | |
PT838222E (pt) | Composicoes de vacina compreendendo imunogenios inactivados e virus da anemia dagalinha (cav) vivos | |
TW377373B (en) | Recombinant raccoon pox viruses and their use as an effective vaccine against feline infectious peritonitis virus disease | |
ES2165840T3 (es) | Vacunas para la hepatitis a. | |
ES532732A0 (es) | Un procedimiento para preparar una vacuna para el virus de la hepatitis b | |
AU2403188A (en) | Infectious bovine rhinotracheitis virus mutants, vaccines containing same, methods for the production of same and methods for the use of same | |
MX9304349A (es) | Vacuna antirrabica no virulenta. | |
WO1994000586A3 (fr) | Mutants et vaccins du virus de la rhinotracheite infectieuse bovine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 513090 Country of ref document: ES |